Adenosine Monophosphate-Activated Protein Kinase (AMPK) as a New Target for Antidiabetic Drugs: A Review on Metabolic, Pharmacological and Chemical Considerations . (2023). The Review of Diabetic Studies , 6(1). https://diabeticstudies.org/index.php/RDS/article/view/252